EXPRESSION OF THE PUTATIVE CANNABINOID RECEPTOR GPR55 IS INCREASED IN ENDOMETRIAL CARCINOMA

被引:0
|
作者
Ayakannu, T. [1 ,2 ]
Anthony, T. [2 ]
Chatterjee, J. [1 ]
Ellis, P. [1 ]
Tailor, A. [1 ]
Davies, Q. [3 ]
Esther, M. [3 ]
Butler-Manuel, S. [1 ]
Konje, J. [2 ,4 ]
机构
[1] Univ Surrey, Royal Surrey Cty Hosp, Guildford Gynaecol Oncol Res Dept, Guildford, Surrey, England
[2] Univ Leicester, Endocannabinoid Res Grp, Reprod Sci Sect, Dept Canc Studies & Mol Med, Leicester, Leics, England
[3] Univ Leicester, Dept Gynaecol Oncol, Leicester, Leics, England
[4] Sidra Med & Res Ctr, Dept Obstet & Gynaecol, Doha, Qatar
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ESGO7-0878
引用
收藏
页码:1229 / 1229
页数:1
相关论文
共 50 条
  • [21] The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
    Staton, Penny C.
    Hatcher, Jon P.
    Walker, Deborah J.
    Morrison, Alastair D.
    Shapland, Ellen M.
    Hughes, Jane P.
    Chong, Elizabeth
    Mander, Palwinder K.
    Green, Paula J.
    Billinton, Andy
    Fulleylove, Michael
    Lancaster, Hilary C.
    Smith, Jason C.
    Bailey, Leigh T.
    Wise, Alan
    Brown, Andrew J.
    Richardson, Jill C.
    Chessell, Iain P.
    PAIN, 2008, 139 (01) : 225 - 236
  • [22] GPR55 as a new cannabinoid receptor: Still a long way to prove it
    Petitet, F
    Donlan, M
    Michel, A
    CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (03) : 252 - 253
  • [23] Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55
    Kotsikorou, Eyangelia
    Lynch, Diane L.
    Abood, Mary E.
    Reggio, Patricia H.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2011, 164 (02) : 131 - 143
  • [24] IS GPR55 AN ANANDAMIDE RECEPTOR?
    Brown, Andrew J.
    Hiley, C. Robin
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 111 - 137
  • [25] Identification and characterisation of putative modulator ligands at the orphan receptor GPR55
    Haslam, C.
    Kitchen, V.
    Brough, S.
    Kassim, M.
    Daniels, D.
    Brown, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 70 - 70
  • [26] A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity
    Hurst, Katrina
    Badgley, Corinne
    Ellsworth, Tanner
    Bell, Spencer
    Friend, Lindsey
    Prince, Brad
    Welch, Jacob
    Cowan, Zack
    Williamson, Ryan
    Lyon, Chris
    Anderson, Brandon
    Poole, Brian
    Christensen, Michael
    McNeil, Michael
    Call, Jarrod
    Edwards, Jeffrey G.
    HIPPOCAMPUS, 2017, 27 (09) : 985 - 998
  • [27] The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
    Sharir, Haleli
    Console-Bram, Linda
    Mundy, Christina
    Popoff, Steven N.
    Kapur, Ankur
    Abood, Mary E.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 (04) : 856 - 865
  • [28] GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
    Lauckner, Jane E.
    Jensen, Jill B.
    Chen, Huei-Ying
    Lu, Hui-Chen
    Hille, Bertil
    Mackie, Ken
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (07) : 2699 - 2704
  • [29] GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors
    Zhao, Pingwei
    Abood, Mary E.
    LIFE SCIENCES, 2013, 92 (8-9) : 453 - 457
  • [30] The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
    Kargl, Julia
    Balenga, Nariman
    Parzmair, Gerald P.
    Brown, Andrew J.
    Heinemann, Akos
    Waldhoer, Maria
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (53) : 44234 - 44248